Friday, October 7, 2022
HomeMost RecentLicensing Application System for Ayurvedic, Siddha and Unani Drug Manufacturers Online

Licensing Application System for Ayurvedic, Siddha and Unani Drug Manufacturers Online

New Delhi:The Ministry of AYUSH is streamlining the procedures for quick, paperless and extra clear utility course of for licensing of Ayurvedic, Siddha and Unani (ASU) pharmaceutical producers.

This eliminates the effort for producers to seem in individual on the workplace of the Licensing Authority. The license might be utilized for on-line at The Ministry of AYUSH has issued a Gazette Notification relating to the implementation of the Medication (4th Modification) Guidelines 2021, efficient from October 1, 2021.

Any more, a one-time license with a one-time registration payment will suffice for the manufacture of Ayurvedic, Siddha and Unani medicines. The product’s license might be legitimate if the self-certification doc is submitted on-line every year till the license is suspended or revoked. Earlier than the announcement, it was 5 years.

Candidates are required to acquire a ‘Good Manufacturing Practices’ certification each 5 years for his or her license to be legitimate. Renewal of GMP Certificates might be accomplished on-line with a payment of Rs.1000 / -. Manufacturing items of Ayurvedic, Siddha and Unani medicines might be randomly inspected each 5 years. Because of the extension, the payment for a generic drug manufacturing license has been revised from Rs 1,000 to Rs 2,000. As much as 10 nos

The license payment for proprietary ASU medicine is Rs.3000.

The ministry has lowered the utmost time for issuing a license from three months to 2 months.

Purposes might be submitted on-line and offline for a interval of six months from the date of gazette notification till it turns into totally on-line.


Click Here To Join Our Telegram Channel

Source Link

You probably have any considerations or complaints relating to this text, please tell us and the article might be eliminated quickly. 

Raise A Concern

- Advertisment -

Most Popular